<DOC>
	<DOCNO>NCT02747173</DOCNO>
	<brief_summary>Prospective observational study ass bone predictive biomarkers TKI response RCC patient bone metastasis HRQoL TKI patient well sensitivity specificity whole body magnetic resonance versus bone scintigraphy versus CT assessment metastatic lesion bone level site .</brief_summary>
	<brief_title>Assessment Bone Biomarkers TKI Response RCC With Bone Metastases , HRQoL Comparison Imaging Techniques</brief_title>
	<detailed_description>Prospective observational study ass : - Bone predictive biomarkers tyrosine kinase inhibitor ( TKI ) response renal cell carcinoma ( RCC ) patient bone metastasis - Health Related Quality Life ( HRQoL ) TKI - Comparison sensitivity specificity whole body magnetic resonance versus bone scintigraphy versus Computerized tomography ( CT ) assessment metastatic lesion bone level site .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<criteria>Diagnosis stage IV renal cell carcinoma confirm presence bone metastasis , subsidiary treatment TKI first line 18 year old Life expectancy &gt; 12 week Eastern Cooperative Oncology Group Performance Status ( ECOG PS ) : 0 2 Capability understand study complete numerical pain scale , diary analgesic Quality Life form Patient give informed consent Adequate renal , hepatic hematologic function Pregnancy , breastfeed fertile patient use adequate contraceptive method Nonclear cell histology Non irradiate brain metastasis Symptomatic brain metastasis Inability undergo medical test study A history breast cancer melanoma . Other tumor accept long patient least 5 year free disease Synchronic diagnosis another neoplasm Presence active infection Any decompensated disease metabolic disorder Cardiac event pulmonary embolism 12 month previous inclusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>metastatic , bone metastasis</keyword>
</DOC>